Purple Biotech (PPBT) Receivables (2019 - 2025)
Purple Biotech (PPBT) reported Receivables of $326000.0 for Q2 2025, up 1381.82% year-over-year from $22000.0 in Q2 2024, and down 30.49% quarter-over-quarter from $469000.0 in Q1 2025.
Purple Biotech (PPBT) Receivables (2019 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 7 years of Receivables data on file, last reported at $326000.0 in Q2 2025.
- Receivables for Q2 2025 came in at $326000.0, up 1381.82% year-over-year; the trailing twelve-month figure through Jun 2025 was $326000.0 (up 1381.82% YoY), and the FY2024 annual result was $276000.0, up 272.97% from the prior year.
- Receivables declined to $326000.0 in Q2 2025 per PPBT's latest filing, from $469000.0 in the prior quarter.
- Over five years, Receivables peaked at $500000.0 in Q1 2021 and troughed at $14000.0 in Q3 2024.
- A 5-year average of $264611.1 and a median of $234500.0 in 2021 frame the typical range for Receivables.
- The sharpest annual moves came in 2024 and 2025: Receivables sank 94.56% in 2024, then surged 2133.33% in 2025.
- A 5-year view of Receivables shows it stood at $193000.0 in 2021, then soared by 123.32% to $431000.0 in 2022, then sank by 82.83% to $74000.0 in 2023, then soared by 272.97% to $276000.0 in 2024, then grew by 18.12% to $326000.0 in 2025.
- Business Quant data shows PPBT's Receivables at $326000.0 in Q2 2025, $469000.0 in Q1 2025, and $276000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 326,000.00 |
| Mar 31, 2025 | 469,000.00 |
| Dec 31, 2024 | 276,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Sep 30, 2023 | 138,000.00 |
| Jun 30, 2023 | 352,000.00 |
| Mar 31, 2023 | 386,000.00 |
| Dec 31, 2022 | 431,000.00 |
| Sep 30, 2022 | 187,000.00 |
| Jun 30, 2022 | 187,000.00 |
| Mar 31, 2022 | 187,000.00 |
| Dec 31, 2021 | 193,000.00 |
| Sep 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Jun 30, 2020 | 1.00 Mn |